Latest revenue
$43.1M
as of 2026-03-31
Latest net income
$11.3M
as of 2026-03-31
Net margin
26.3%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $315.7M
- Enterprise value
- $315.7M
- P/E (trailing)
- 6.2×
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $5.75
- 52-wk low
- $2.78
- Beta
- —
- Shares out
- 102.8M
5-year trend
What this company does
Item 1. Business. Unless the context indicates otherwise, any references herein to the “Company”, “we”, “us” and “our” refer to (i) SBC Medical Group, Inc. (formerly known as SBC Medical Group Holdings Incorporated), a Delaware corporation (“Legacy SBC”), and its consolidated subsidiaries and variable interest entity (“VIE”), prior to the consummation of the Business Combination and to (ii) SBC Medical Group Holdings Incorporated, the Combined Entity and its consolidated subsidiaries and VIE following the Business Combination, and reference herein to “Pono” refers to Pono Capital Two, Inc., the predecessor company prior to the consummation of the Business Combination. Company Overview…
AI summary unavailable — showing raw filing excerpt
Generated from SBC's filing dated 2026-03-27
Key risks
Item 1A. Risk Factors An investment in our securities carries a significant degree of risk. You should carefully consider the following risks, as well as the other information contained in this Annual Report, including our historical financial statements and related notes included elsewhere in this Annual Report, before you decide to purchase our securities. Any one of these risks and uncertainties has the potential to cause material adverse effects on our business, prospects, financial condition and operating results which could cause actual results to differ materially from any forward-looking statements expressed by us and a significant decrease in the value of our common shares and…
AI summary unavailable — showing raw filing excerpt
Generated from SBC's filing dated 2026-03-27
Profitability
Gross margin
73.3%
3.5%Operating margin
38.9%
13.6%Net margin
29.4%
29.4%Return on equity
20.5%
14.0%Return on assets
13.4%
23.5%Leverage
Debt / equity
0.53×
46.3%Long-term debt / equity
0.14×
307.7%Debt / assets
34.7%
30.2%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $43.1M | -9.0% | $11.3M | -47.4% | 26.3% |
Q4 2025 2025-12-31 | $39.6M | -10.9% | $14.2M | -68.0% | 35.9% |
Q3 2025 2025-09-30 | $43.4M | -18.3% | $12.8M | +352.7% | 29.6% |
Q2 2025 2025-06-30 | $43.4M | -18.3% | $2.5M | +897.4% | 5.7% |
Q1 2025 2025-03-31 | $47.3M | -13.6% | $21.5M | +7450.1% | 45.4% |
Q4 2024 2024-12-31 | $44.4M | — | $44.4M | — | 99.9% |
Q3 2024 2024-09-30 | $53.1M | +12.3% | $2.8M | +2810.0% | 5.3% |
Q2 2024 2024-06-30 | $53.1M | — | $-308.3K | -256.7% | -0.6% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Services-Offices & Clinics of Doctors of Medicine · SIC 8011
Your notes
Keep private notes on SBC — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$20.2M
Net activity
−$20.2M
Distinct insiders
1
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns SBC
Institutional value
$3.6M
Total shares held
850.8K
Distinct holders
28
-14 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 419.6K | $1.8M | -6.9K (-1.6%) | Trimmed |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 136.2K | $569.5K | — | New |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 63.5K | $265.6K | — | New |
| 4 | VANGUARD FIDUCIARY TRUST CO | 62.5K | $261.1K | — | New |
| 5 | SBI Securities Co., Ltd. | 45.1K | $188.4K | -2.9K (-6.0%) | Trimmed |
| 6 | Mariner, LLC | 24.0K | $100.2K | — | New |
| 7 | NEW YORK STATE COMMON RETIREMENT FUND | 17.0K | $71.1K | +0 (+0.0%) | No change |
| 8 | Williams & Novak, LLC | 14.2K | $62.6K | -943 (-6.2%) | Trimmed |
| 9 | Russell Investments Group, Ltd. | 13.6K | $56.8K | +1.8K (+15.4%) | Added |
| 10 | Nuveen, LLC | 12.4K | $51.7K | +0 (+0.0%) | No change |
| 11 | Bank of New York Mellon Corp | 10.2K | $42.6K | — | New |
| 12 | Vanguard Global Advisers, LLC | 8.6K | $35.8K | — | New |
| 13 | RHUMBLINE ADVISERS | 6.4K | $26.9K | +1.1K (+21.3%) | Added |
| 14 | JPMORGAN CHASE & CO | 4.6K | $18.8K | -4.4K (-49.1%) | Trimmed |
| 15 | WELLS FARGO & COMPANY/MN | 4.3K | $17.8K | -8.4K (-66.3%) | Trimmed |
| 16 | UBS Group AG | 3.7K | $15.6K | -2.0K (-35.2%) | Trimmed |
| 17 | BNP PARIBAS FINANCIAL MARKETS | 2.5K | $10.4K | +0 (+0.0%) | No change |
| 18 | CITIGROUP INC | 594 | $2.5K | +339 (+132.9%) | Added |
| 19 | Ameritas Investment Partners, Inc. | 577 | $2.4K | +0 (+0.0%) | No change |
| 20 | Legal & General Group Plc | 514 | $2.1K | +0 (+0.0%) | No change |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once SBC's latest filing finishes processing.